评估2019年冠状病毒病大流行期间社区卫生中心虚拟糖尿病小组就诊的效果。
Evaluating Effects of Virtual Diabetes Group Visits in Community Health Centers During the COVID-19 Pandemic.
作者信息
Dinh Tracy, Staab Erin M, Nuñez Daisy, Zhu Mengqi, Wan Wen, Schaefer Cynthia T, Campbell Amanda, Quinn Michael, Baig Arshiya A
机构信息
Department of Medicine, University of Chicago, Chicago, IL, USA.
Midwest Clinicians' Network, East Lansing, MI, USA.
出版信息
J Patient Exp. 2023 Sep 7;10:23743735231199822. doi: 10.1177/23743735231199822. eCollection 2023.
Diabetes is the seventh leading cause of death in the US. Diabetes group visits (GVs), which include group education and individual medical visits have been shown to improve clinical outcomes. However, few studies have evaluated virtual GVs. We conducted a single-arm pilot study to test the impact of virtual diabetes GVs in Midwestern community health centers (CHCs). Adult patients with diabetes participated in monthly virtual GVs for 6 months. Surveys and chart abstraction were used to assess patient-reported and clinical outcomes. Five CHCs implemented virtual GVs with 34 patients attending at least one session. Virtual GVs show promise as evidenced by these findings: (1) Patients had a nonsignificant decrease in A1C. (2) In the subgroup of patients with baseline A1C ≥ 9%, there was a significant decrease in A1C. (3) Patients had significant increases in diabetes knowledge and support as well as a decrease in diabetes distress. Future studies with a larger sample size and a control comparison group are needed to assess the impact of virtual GVs on patient outcomes.
糖尿病是美国第七大死因。糖尿病小组就诊（GVs），包括小组教育和个体医疗就诊，已被证明可改善临床结局。然而，很少有研究评估虚拟小组就诊。我们开展了一项单臂试点研究，以测试虚拟糖尿病小组就诊在中西部社区卫生中心（CHCs）的影响。成年糖尿病患者参加了为期6个月的每月一次虚拟小组就诊。通过调查和病历摘要来评估患者报告的结局和临床结局。5家社区卫生中心实施了虚拟小组就诊，34名患者至少参加了一次就诊。这些结果表明虚拟小组就诊具有前景：（1）患者糖化血红蛋白（A1C）水平有不显著下降。（2）在基线A1C≥9%的患者亚组中，A1C有显著下降。（3）患者的糖尿病知识和支持显著增加，糖尿病困扰减少。需要开展样本量更大且有对照比较组的未来研究，以评估虚拟小组就诊对患者结局的影响。
Zotero 插件